| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 10/08/2008 | CN101282943A Pyrimidine amide compounds as PGDS inhibitors |
| 10/08/2008 | CN101282937A Therapeutic agents |
| 10/08/2008 | CN101279952A Method for preparing 1,3-dimethyl alkyleneurea by methylation by step |
| 10/08/2008 | CN101279951A 2-pyrimindinyloxy (pyrimindinylthio) benzoxy enoates compound and application thereof |
| 10/08/2008 | CN101279950A 2-pyrimindinyloxy (pyrimindinylthio) benzoxy acetamide compound and application thereof |
| 10/08/2008 | CN101279949A Method for synthesizing 2-hydroxyl-4,6-dimethylpyrimidine |
| 10/08/2008 | CN101279948A Synthetic method of 4,6- dichloro-5-(2-methoxyphenoxy)-2,2í»-dipyridine |
| 10/08/2008 | CN100424083C Pyrimidine derivative compound and its preparing method |
| 10/08/2008 | CN100424079C Bis-sulfonamides |
| 10/08/2008 | CN100424078C Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 10/07/2008 | US7432400 sun protection agents; diketone |
| 10/07/2008 | US7432392 Ester derivatives and medical use thereof |
| 10/07/2008 | US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors |
| 10/07/2008 | US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance |
| 10/07/2008 | US7432281 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist |
| 10/07/2008 | US7432275 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 10/07/2008 | US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain |
| 10/07/2008 | CA2433772C Pyrimidine matrix metalloproteinase inhibitors |
| 10/07/2008 | CA2362831C Thioamide derivatives |
| 10/02/2008 | WO2008118822A1 Compositions and methods for inhibition of the jak pathway |
| 10/02/2008 | WO2008117884A1 Process for producing trichloropyrimidine compound |
| 10/02/2008 | WO2008117826A1 Compound for organic electroluminescent device and organic electroluminescent device |
| 10/02/2008 | WO2008117060A2 Co-crystals of cyprodinil and pyrimethanil |
| 10/02/2008 | US20080242863 Process For the Manufacture of a Precursor of Vitamin B1 |
| 10/02/2008 | US20080242861 Synthesis of amino-protected cyclohexane-1,4-diyldimethanamine and its derivatives |
| 10/02/2008 | US20080242681 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors |
| 10/02/2008 | US20080241591 Organic electroluminescence device and phenylenediamine derivative |
| 10/02/2008 | CA2680511A1 Co-crystals of cyprodinil and pyrimethanil |
| 10/01/2008 | EP1973885A1 Aminopyrimidine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same |
| 10/01/2008 | EP1372655B1 Cathepsin cysteine protease inhibitors |
| 10/01/2008 | CN101277951A 2-aminopyrimidine derivatives as modulators of the histamine H4 receptor activity |
| 10/01/2008 | CN101277948A Chemical process |
| 10/01/2008 | CN101277939A Acyclic ikur inhibitors |
| 10/01/2008 | CN101277700A Pyrimidine compounds as serotonin receptor modulators |
| 10/01/2008 | CN101274908A Organic selenide synthetic method using environment-friendly catalyst |
| 10/01/2008 | CN100422157C Improved production of rosuvastatin calcium salt |
| 10/01/2008 | CN100422147C Method of preparing compound of 0-substituted sulphonyl propylhomoserin class |
| 10/01/2008 | CN100421663C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine A2A receptor antagonists |
| 09/30/2008 | US7429667 suc as 5-[4-(2,5-Dichloro-phenoxy)-3-fluoro-phenylamino]-3-hydroxy-N-isopropyl-isothiazole-4-carboxamidine; anticarcinogenic agent |
| 09/30/2008 | US7429666 Pyridine analogs as C5a antagonists |
| 09/30/2008 | US7429604 Six-membered heterocycles useful as serine protease inhibitors |
| 09/30/2008 | US7429599 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| 09/30/2008 | US7429598 Spirocondensed quinazolinones and their use as phosphodiesterase inhibitors |
| 09/30/2008 | US7429597 Heterobicyclic compound such as quinazoline anticoagulants and factor X inhibitors |
| 09/30/2008 | US7429593 Utilities of amide compounds |
| 09/30/2008 | US7429586 Non-imidazole aryloxyalkylamines |
| 09/30/2008 | CA2417417C Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 09/30/2008 | CA2381001C Carbamate derivative and agricultural/horticultural fungicide |
| 09/30/2008 | CA2195856C Substituted o6-benzylguanines and use thereof |
| 09/25/2008 | WO2008115738A1 Chemical compounds |
| 09/25/2008 | WO2008114275A2 Anthranilic acid derivatives as anticancer agents and process for the preparation thereof |
| 09/25/2008 | WO2008113881A1 Compound that is a dual inhibitor of enzymes pde7 and/or pde4, pharmaceutical compositions and uses thereof |
| 09/25/2008 | US20080234481 Forming salts such as tartrate or mandelate ; chemical intermediate |
| 09/25/2008 | US20080234302 Novel Processes for Preparing Amorphous Rosuvastatin Calcium and a Novel Polymorphic Form of Rosuvastatin Sodium |
| 09/25/2008 | US20080234301 Alpha-4 Integrin Mediated Cell Adhesion Inhibitors for the Treatment or Prevention of Inflammatory Diseases |
| 09/25/2008 | US20080234299 Quinazolinones |
| 09/25/2008 | US20080234293 Tri-aryl/heteroaromatic cannabinoids and use thereof |
| 09/25/2008 | US20080234276 Heterocyclic Triazines as Hypoxic Selective Protein Kinase Inhibitors |
| 09/25/2008 | US20080234273 Such as 3-{[4-(azetidin-1-ylcarbonyl)-2-chlorophenyl]oxy}-5-({(1S)-2-[(difluoromethyl)oxy]-1-methylethyl}oxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinases (Glk) |
| 09/25/2008 | US20080234254 anticarcinogenic agents for treating leukaemia, non-small cell lung cancers, colonic cancers, breast cancers, ovarian cancers, renal cancers and melanoma; in vivo hydrolysable ester or amide; N-(2-amino-phenyl)-4-[1-(3,4-dihydroisoquinolin-2(1H)-ylmethyl)vinyl]benzamide; solid phase synthesis |
| 09/25/2008 | US20080230058 Dry powder dispersing apparatus and methods for their use |
| 09/25/2008 | CA2682259A1 Compound that is a dual inhibitor of enzymes pde7 and/or pde4, pharmaceutical compositions and uses thereof |
| 09/25/2008 | CA2681516A1 Compounds useful as inhibitors of janus kinases |
| 09/25/2008 | CA2681248A1 Chemical compounds |
| 09/24/2008 | EP1972620A1 Synthesis of 4-amino-pyrimidines |
| 09/24/2008 | EP1971579A1 2-(poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides |
| 09/24/2008 | EP1971576A2 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 09/24/2008 | EP1465877B1 Positive-working photoimageable bottom antireflective coating |
| 09/24/2008 | CN101273048A Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes |
| 09/24/2008 | CN101273035A Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/24/2008 | CN101273034A Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/24/2008 | CN101273015A 3-cyclyl-2- (4-sulfamo yl-phenyl) -N-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
| 09/24/2008 | CN101270133A Organometallic complex and light emitting element, light emitting device, and electronic device using the organometallic complex |
| 09/24/2008 | CN101270081A Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 09/24/2008 | CN101269076A Medicine use of beta-methoxy acrylic ester compounds as novel STAT3 restrainer |
| 09/24/2008 | CN100420688C Pyrimido[4,5-d]pyrimidine derivatives with anticancer activity |
| 09/24/2008 | CN100420676C Gefitinib synthesis intermediate, and its preparing method and use |
| 09/23/2008 | US7427693 used in flat panel displays, for lowering threshold voltage, improving heat resistance, photostability, contrast ratio and for increasing the dielectric anisotropy and switching speeds |
| 09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 09/23/2008 | US7427628 N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine; antiinflammatory, antiarthritic agents |
| 09/23/2008 | US7427625 Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors |
| 09/23/2008 | US7427615 3-substituted-4-pyrimidone derivatives |
| 09/23/2008 | US7427614 treatment of glaucoma or ocular hypertension; N-substituted hexahydropyrimidin-2-ones, perhydro-1,3-oxazin-2-ones and perhydro-1,3-thiazin-2-ones |
| 09/23/2008 | CA2283570C Aminosulfonylureas with herbicidal activity |
| 09/18/2008 | WO2008112913A1 Inhibitors of the hedgehog pathway |
| 09/18/2008 | WO2008112317A2 Triol form of rosuvastatin |
| 09/18/2008 | WO2008109943A1 Phenyl amino pyrimidine compounds and uses thereof |
| 09/18/2008 | WO2008061112A9 Pharmaceutical compounds as inhibitors of cell proliferation and the use thereof |
| 09/18/2008 | US20080227799 treating or reducing the severity of hyperproliferative diseases by inhibiting metastasis |
| 09/18/2008 | US20080227782 Pyrimidine amide compounds as pgds inhibitors |
| 09/18/2008 | US20080227776 inhibiting heme-induced lipid peroxidation; preventing isoprostane-mediated tissue damage |
| 09/18/2008 | US20080226674 Anticancer drugs encapsulated in and mixed with envelop protein virus vector; intensify immunology response in animals |
| 09/18/2008 | CA2702650A1 Phenyl amino pyrimidine compounds and uses thereof |
| 09/18/2008 | CA2680796A1 Inhibitors of the hedgehog pathway |
| 09/17/2008 | EP1970373A1 Alicyclic heterocyclic compound |
| 09/17/2008 | EP1968968A1 Compositions and methods for modulating gated ion channels |
| 09/17/2008 | EP1968950A1 Pyrimidine kinase inhibitors |
| 09/17/2008 | EP1893586B1 Method for production of 1-alkyl-3-phenyluracils |
| 09/17/2008 | EP1604991B1 Antitumor effect potentiator and antitumor agent |
| 09/17/2008 | EP1597239B1 Polymorph of {6,7-bis(2-methoxy-ethoxy)-quinazolin-4-yl}-(3e) |